"Ghost", a Well-Known but Not Fully Explained Echocardiographic Finding during Transvenous Lead Extraction: Clinical Significance.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
01 10 2022
Historique:
received: 11 09 2022
revised: 25 09 2022
accepted: 26 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

"Ghosts" are fibrinous remnants that become visible during transvenous lead extraction (TLE). Data from transoesophageal echocardiography-guided TLE procedures performed in 1103 patients were analysed to identify predisposing risk factors for the development of so-called disappearing ghosts-flying ghosts (FG), or attached to the cardiovascular wall-stable ghosts (SG), and to find out whether the presence of ghosts affected patient prognosis after TLE. Ghosts were detected in 44.67% of patients (FG 15.5%, SG 29.2%). The occurrence of ghosts was associated with patient age at first system implantation [FG (OR = 0.984; The degree of growth and maturation of scar tissue surrounding the lead was the strongest factor leading to the development of both types of ghosts. The presence of either form of ghost did not affect long-term survival even after TLE indicated for infection.

Identifiants

pubmed: 36231841
pii: ijerph191912542
doi: 10.3390/ijerph191912542
pmc: PMC9565986
pii:
doi:

Substances chimiques

Lead 2P299V784P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Eur Heart J Cardiovasc Imaging. 2014 Aug;15(8):926-32
pubmed: 24686256
Europace. 2018 Jun 1;20(6):1018-1027
pubmed: 29016771
Heart Rhythm. 2017 Dec;14(12):e503-e551
pubmed: 28919379
J Arrhythm. 2017 Dec;33(6):640-642
pubmed: 29255516
Echocardiography. 2019 Jan;36(1):201-203
pubmed: 30536885
Int J Cardiol. 2008 Jul 4;127(2):e67-8
pubmed: 17588687
Heart Rhythm. 2018 Nov;15(11):1593-1600
pubmed: 30654978
Echo Res Pract. 2019 Jul 31;6(3):I3-I4
pubmed: 31475073
J Clin Med. 2020 Aug 08;9(8):
pubmed: 32784437
Int J Environ Res Public Health. 2021 Feb 14;18(4):
pubmed: 33672931
Heart Rhythm. 2013 Dec;10(12):1826
pubmed: 22659214
Heart Rhythm. 2014 Dec;11(12):2196-201
pubmed: 25111324
Front Cardiovasc Med. 2020 Nov 30;7:602179
pubmed: 33330664
JACC Cardiovasc Imaging. 2010 Jul;3(7):673-81
pubmed: 20633844
Europace. 2017 Mar 01;19(3):432-440
pubmed: 27025772
J Clin Med. 2020 May 08;9(5):
pubmed: 32397115
Heart Rhythm. 2009 Jul;6(7):1085-104
pubmed: 19560098
J Interv Card Electrophysiol. 2018 Apr;51(3):253-261
pubmed: 29476380
J Cardiovasc Med (Hagerstown). 2019 Jun;20(6):372-378
pubmed: 30950985
Biomark Med. 2022 Apr;16(5):341-348
pubmed: 35234522
Kardiol Pol. 2020 Dec 23;78(12):1206-1214
pubmed: 33078921
CASE (Phila). 2018 Oct 17;3(1):35-38
pubmed: 30828682
Europace. 2012 Jan;14(1):117-23
pubmed: 21893512
Pacing Clin Electrophysiol. 2022 Feb;45(2):188-195
pubmed: 34978742
Eur J Echocardiogr. 2009 Mar;10(2):343
pubmed: 19147697
Clin Physiol Funct Imaging. 2021 Jan;41(1):25-41
pubmed: 32949059
Europace. 2012 Jul;14(7):994-1001
pubmed: 22247274
Folia Morphol (Warsz). 2000;59(1):25-9
pubmed: 10774088
Int J Cardiovasc Imaging. 2020 Mar;36(3):423-430
pubmed: 31734932
Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e007726
pubmed: 32628867
Echocardiography. 2020 Apr;37(4):601-611
pubmed: 32154950
Pacing Clin Electrophysiol. 2019 Mar;42(3):341-348
pubmed: 30620091
Cardiovasc Diagn Ther. 2021 Apr;11(2):394-410
pubmed: 33968618
Europace. 2018 Jul 1;20(7):1217
pubmed: 29566158
J Am Soc Echocardiogr. 2008 Jul;21(7):861-7
pubmed: 18313266
JACC Clin Electrophysiol. 2019 Jun;5(6):657-664
pubmed: 31221351

Auteurs

Dorota Nowosielecka (D)

Department of Cardiology, The Pope John Paul II Province Hospital, 22-400 Zamość, Poland.
Department of Cardiac Surgery, The Pope John Paul II Province Hospital, 22-400 Zamość, Poland.

Wojciech Jacheć (W)

2nd Department of Cardiology, Faculty of Medical Sciences, Silesian Medical University, 41-800 Zabrze, Poland.

Anna Polewczyk (A)

Institute of Medical Sciences, Jan Kochanowski University, 25-369 Kielce, Poland.
Department of Cardiac Surgery, Świętokrzyskie Cardiology Center, 25-736 Kielce, Poland.

Łukasz Tułecki (Ł)

Department of Cardiac Surgery, The Pope John Paul II Province Hospital, 22-400 Zamość, Poland.

Paweł Stefańczyk (P)

Department of Cardiology, The Pope John Paul II Province Hospital, 22-400 Zamość, Poland.

Andrzej Kutarski (A)

Department of Cardiology, Medical University, 20-059 Lublin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH